Zobrazeno 1 - 10
of 59
pro vyhledávání: '"P. E. Belchetz"'
Publikováno v:
Clinical Endocrinology. 46:123-128
OBJECTIVE We describe four patients with ovarian hyperthecosis and the effects of gonadotrophin releasing hormone on clinical and metabolic variables. DESIGN Open out-patient study. PATIENTS Four women presented with post-menopausal hirsuties. They h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb69be13948995af46c6d6e119425381
https://doi.org/10.1046/j.1365-2265.1997.1050916.x
https://doi.org/10.1046/j.1365-2265.1997.1050916.x
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:4484-4487
We present clinical details of a patient with a 20-yr history of amennorhea, a pituitary tumor, elevated PRL levels, and initially undetectable GH. Bromocriptine failed to fully suppress PRL, and there was no tumor shrinkage. Within 7 months of start
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9b0fcf10894bf5483cec58b2f5f8ae
https://doi.org/10.1210/jcem.81.12.8954064
https://doi.org/10.1210/jcem.81.12.8954064
Autor:
P. E. Belchetz, Brian Oldroyd, S. P. Stewart, Michael A. Smith, M Simpson, S. M. Orme, C.F. Westmacott
Publikováno v:
Clinical Endocrinology. 41:245-250
Summary OBJECTIVE Our clinical practice has been to offer treatment with cyclical disodlum etidronate and high dose calcium supplements (1500–1600 mg/day) to ail female patients with osteoporosis who are unable or unwilling to take hormone replacem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ada4322ae17a81c584ee78e0db15b1
https://doi.org/10.1111/j.1365-2265.1994.tb02537.x
https://doi.org/10.1111/j.1365-2265.1994.tb02537.x
Publikováno v:
Clinical Endocrinology. 39:253-256
Summary We wish to report two cases of congenital cyanotic heart disease in whom coexisting thyrotoxicosis increased the right to left shunt. We review the literature on the cardiac and respiratory effects of thyroid hormone to try to explain this ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db15ae74961cc0e1dcbd6334ae7942a
https://doi.org/10.1111/j.1365-2265.1993.tb01783.x
https://doi.org/10.1111/j.1365-2265.1993.tb01783.x
Publikováno v:
Thrombosis and Haemostasis. 70:1009-1013
SummaryIn vitro studies have shown that insulin and IGF-1 releases the fibrinolytic inhibitor plasminogen activator inhibitor-1 (PAI-1) from cells of hepatic origin. To investigate the effects of IGF-1 on fibrinolysis: 1) cultured hepatoma cells were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af625d615573dc5ac54c7bdbf5ad524c
https://doi.org/10.1055/s-0038-1649716
https://doi.org/10.1055/s-0038-1649716
Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy
Autor:
S. M. Orme, J. P. Sebastian, M. H. Stickland, S. P. Stewart, P. E. Belchetz, Michael A. Smith, P. J. Grant, Brian Oldroyd
Publikováno v:
Clinical Endocrinology. 37:453-459
OBJECTIVE We assessed the effects of the administration of low dose growth hormone in growth hormone deficient adults on body composition and physical performance. We compared the validity of different measures of body composition in GH treated adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3891108ec9187e4c293a037484ca42f1
https://doi.org/10.1111/j.1365-2265.1992.tb02358.x
https://doi.org/10.1111/j.1365-2265.1992.tb02358.x
Publikováno v:
Clinical Endocrinology. 37:379-384
An example of oncogenous osteomalacia is described in association with the rate mesenchymal chondroblastoma. The tumour was characterized with a variety of immunohistochemical antibodies which confirmed its mesenchymal origin. Despite several surgica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::207649d63a7c21a2a49f3da931deae21
https://doi.org/10.1111/j.1365-2265.1992.tb02342.x
https://doi.org/10.1111/j.1365-2265.1992.tb02342.x
Autor:
A Waise, P E Belchetz
Publikováno v:
BMJ. 321:1275-1277
Thyroid testing is increasingly used as a tool for identifying cases of thyroid disease in both primary and secondary care even in the absence of a strong clinical suspicion of disease. Patients with unsuspected thyroid disease are, therefore, likely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57e88b64564d3caa2089a67c2e5788e8
https://doi.org/10.1136/bmj.321.7271.1275
https://doi.org/10.1136/bmj.321.7271.1275
Autor:
Inês Barroso, Alan J. Schafer, Stephen O'Rahilly, Jimmy D. Bell, Ian A McFarlane, David B. Savage, P. E. Belchetz, Maria A. Soos, David Halsall, W. F. Kelly, I. Scobie, E. L. Thomas, A. Powlson
Publikováno v:
Diabetologia. 47(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a83cd710c118a87b25ac91d6f1279a6
https://pubmed.ncbi.nlm.nih.gov/15298354
https://pubmed.ncbi.nlm.nih.gov/15298354
Publikováno v:
International journal of clinical practice. 56(1)
Amiodarone is a heavily iodinated drug effective in the control of various tachyarrhythmias. Despite its undoubted benefit, treatment with amiodarone is not without risk, because a number of potentially serious side-effects may develop during therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d49f713a56cac64dffddea50542ca401
https://pubmed.ncbi.nlm.nih.gov/11831834
https://pubmed.ncbi.nlm.nih.gov/11831834